Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 467645011 | Piroxicam 20mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 467646012 | Piroxicam-beta-cyclodextrin 191.2mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 720424018 | Piroxicam 20mg tablet (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1191969017 | Piroxicam 20mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3470399015 | Product containing piroxicam 20 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3489662011 | Product containing piroxicam 20 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3500991012 | Piroxicam 20 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3567375013 | Product containing only piroxicam 20 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3567376014 | Product containing only piroxicam 20 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3682085018 | Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3682086017 | Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Is a | Piroxicam product | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Is a | Product containing piroxicam | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Has active ingredient | Piroxicam | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Is a | Product containing piroxicam in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Has active ingredient | Piroxicam | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Has basis of strength substance | Piroxicam | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Has precise active ingredient | Piroxicam | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Is a | Product containing only piroxicam in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Piroxicam-beta-cyclodextrin 191.3mg tablet | Is a | False | Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR